| Q2 2024 |
27 |
$7.53M |
+$2.77M |
-$7.6M |
-$4.84M |
VANI, CORZW, RDHL, GWAV, ELTK
|
13F-HR |
8/14/2024, 07:08 AM |
| Q1 2024 |
44 |
$15.3M |
+$13M |
-$8.2M |
+$4.85M |
VANI, ELTK, RDHL, TNXP, GMM
|
13F-HR |
5/15/2024, 07:51 AM |
| Q4 2023 |
46 |
$11.3M |
+$7.49M |
-$25.7M |
-$18.2M |
TNXP, BCAN, MMAT, PHUN, RCON
|
13F-HR |
2/14/2024, 06:44 AM |
| Q3 2023 |
66 |
$31.6M |
+$23M |
-$41.6M |
-$18.6M |
IWM, SPY, SEEL, TC, RCON
|
13F-HR |
11/14/2023, 07:25 AM |
| Q2 2023 |
68 |
$27.9M |
+$16.3M |
-$13.8M |
+$2.5M |
BIOR, SONNXXXX, AKTX, SIDU, RCON
|
13F-HR |
8/14/2023, 05:17 PM |
| Q1 2023 |
72 |
$26.9M |
+$16M |
-$22.8M |
-$6.74M |
NMTRQ, AKTX, TC, DOGZ, RCON
|
13F-HR |
5/15/2023, 09:09 AM |
| Q4 2022 |
89 |
$37.3M |
+$15.9M |
-$14.5M |
+$1.46M |
NVCT, TBLT, DOGZ, TC, IWM
|
13F-HR |
2/14/2023, 08:40 AM |
| Q3 2022 |
83 |
$44.4M |
+$23.3M |
-$26.7M |
-$3.37M |
BGXX, NVCT, DOGZ, BLRX, AKTX
|
13F-HR |
11/14/2022, 09:28 AM |
| Q2 2022 |
76 |
$53.7M |
+$25.3M |
-$187M |
-$161M |
GEVO, DOGZ, MMAT, COCP, PMCB
|
13F-HR |
8/15/2022, 08:16 AM |
| Q1 2022 |
83 |
$233M |
+$16.3M |
-$108M |
-$92M |
COCP, PMCB, BIVI, NISN, CNTX
|
13F-HR |
5/16/2022, 08:34 AM |
| Q4 2021 |
104 |
$401M |
+$87.3M |
-$50.5M |
+$36.8M |
BTBT, NISN, SRNE, ESPR, VXXXXXX
|
13F-HR |
2/14/2022, 07:54 AM |
| Q3 2021 |
94 |
$456M |
+$111M |
-$54.8M |
+$56.2M |
BTBT, BTCM, SRNE, VXXXXXX, COCP
|
13F-HR |
11/15/2021, 08:25 AM |
| Q2 2021 |
85 |
$462M |
+$389M |
-$53.5M |
+$336M |
SRNE, COCP, RENB, ATOS, ATER
|
13F-HR |
8/16/2021, 09:14 AM |
| Q1 2021 |
82 |
$136M |
+$124M |
-$88.2M |
+$36.3M |
SRNE, EYES, ASXC, NBEVQ, WIMI
|
13F-HR |
5/14/2021, 05:44 PM |
| Q4 2020 |
53 |
$104M |
+$55.7M |
-$63.5M |
-$7.84M |
BIIB, AZN, MRNA, XWEL, CVM
|
13F-HR |
2/16/2021, 09:00 AM |
| Q3 2020 |
68 |
$110M |
+$81M |
-$47.8M |
+$33.2M |
BIIB, MRNA, AZN, SRNE, IMMU
|
13F-HR |
11/16/2020, 09:09 AM |
| Q2 2020 |
50 |
$77M |
+$67.4M |
-$23.3M |
+$44.2M |
BIIB, XLV, MRNA, XERS, PLLXXXX
|
13F-HR |
8/14/2020, 08:48 AM |
| Q1 2020 |
57 |
$28.9M |
+$20.6M |
-$15.4M |
+$5.14M |
XLV, GLD, NOVNXXXX, ENLV, OTLK
|
13F-HR |
5/15/2020, 05:00 PM |
| Q4 2019 |
47 |
$27.1M |
+$14.8M |
-$21.4M |
-$6.58M |
GLD, ONTX, ODTC, GNCA, BPTH
|
13F-HR |
2/14/2020, 04:11 PM |
| Q3 2019 |
65 |
$35.7M |
+$16.6M |
-$12.8M |
+$3.84M |
TEUM, ODTC, ATNM, CJJDXXXX, CRMD
|
13F-HR |
11/14/2019, 06:17 PM |
| Q2 2019 |
65 |
$38.4M |
+$24M |
-$17.9M |
+$6.14M |
ODTC, ATNM, AMPE, CJJDXXXX, GNCA
|
13F-HR |
8/14/2019, 04:04 PM |
| Q1 2019 |
52 |
$32.1M |
+$8.46M |
-$73.9M |
-$65.5M |
ODTC, BCLI, ORMP, LOOP, SOLO
|
13F-HR |
5/15/2019, 05:10 PM |
| Q4 2018 |
86 |
$93.6M |
+$51.3M |
-$33M |
+$18.3M |
BIIB, ESPR, XBI, BCLI, XERS
|
13F-HR |
2/13/2019, 05:56 PM |
| Q3 2018 |
75 |
$112M |
+$25.1M |
-$87.8M |
-$62.6M |
NKTR, BIIB, ODTC, XERS, UMRX
|
13F-HR |
11/13/2018, 06:14 PM |
| Q2 2018 |
84 |
$174M |
+$83.2M |
-$60.3M |
+$22.9M |
BIIB, NVO, ODTC, NKTR, XERS
|
13F-HR |
8/14/2018, 08:48 AM |
| Q1 2018 |
86 |
$156M |
+$118M |
-$113M |
+$4.94M |
BIIB, ODTC, SPY, UMRX, INCY
|
Restatement |
5/15/2018, 03:35 PM |
| Q4 2017 |
79 |
$145M |
+$64.7M |
-$36.6M |
+$28.1M |
BMY, ODTC, ESPR, ONCE, MNKD
|
Restatement |
2/15/2018, 02:15 PM |
| Q3 2017 |
79 |
$122M |
+$87.6M |
-$180M |
-$92.3M |
BMY, AXGT, ESPR, ONS, GWPH
|
13F-HR |
11/14/2017, 09:32 AM |
| Q2 2017 |
112 |
$218M |
+$163M |
-$77.4M |
+$85.3M |
TSRO, UTHR, SGEN, BIOAQ, SPNC
|
Restatement |
9/27/2017, 11:49 AM |
| Q1 2017 |
123 |
$142M |
+$52.2M |
-$244M |
-$192M |
BMY, AMGN, ONS, IONS, MTFB
|
Restatement |
5/16/2017, 10:09 AM |
| Q4 2016 |
152 |
$332M |
+$183M |
-$73.3M |
+$110M |
REGN, SRPT, AMGN, BMY, LLY
|
13F-HR |
2/13/2017, 06:55 PM |
| Q3 2016 |
143 |
$277M |
+$70.2M |
-$126M |
-$55.8M |
SRPT, REGN, AMGN, ONS, BMY
|
13F-HR |
11/14/2016, 09:37 AM |
| Q2 2016 |
148 |
$288M |
+$125M |
-$124M |
+$757K |
REGN, AMGN, SRPT, ABT, ONS
|
13F-HR |
8/15/2016, 10:06 AM |
| Q1 2016 |
166 |
$300M |
+$195M |
-$138M |
+$56.9M |
SPY, AMGN, REGN, SRPT, BIIB
|
13F-HR |
5/13/2016, 04:54 PM |
| Q4 2015 |
152 |
$287M |
+$109M |
-$289M |
-$180M |
IWM, GWPH, ALKS, VPCOU, TENX
|
13F-HR |
2/16/2016, 09:37 AM |
| Q3 2015 |
194 |
$488M |
+$315M |
-$163M |
+$152M |
IWM, BIIB, BMRN, MYL, PXD
|
13F-HR |
11/16/2015, 10:06 AM |
| Q2 2015 |
137 |
$395M |
+$242M |
-$197M |
+$45.5M |
TLT, MRK, GBSNU, XOM, PXD
|
13F-HR |
8/14/2015, 11:17 AM |
| Q1 2015 |
123 |
$353M |
+$221M |
-$210M |
+$10.7M |
B108PS, IWM, ZGNX, MBBYF, IOC
|
13F-HR |
5/15/2015, 09:25 AM |
| Q4 2014 |
102 |
$341M |
+$196M |
-$82.5M |
+$114M |
PFE, ACAD, B108PS, AZN, IOC
|
13F-HR |
2/17/2015, 06:19 AM |
| Q3 2014 |
106 |
$206M |
+$138M |
-$239M |
-$101M |
B108PS, IOC, TENX, GEVA, TSLA
|
Restatement |
11/18/2014, 04:03 PM |
| Q2 2014 |
100 |
$332M |
+$221M |
-$86.4M |
+$134M |
WY, TEVA, REGN, ACAD, OXBT
|
13F-HR |
8/14/2014, 09:58 AM |
| Q1 2014 |
82 |
$206M |
+$138M |
-$105M |
+$32.2M |
TEVA, OXBT, ACAD, GILD, BPTH
|
13F-HR |
5/13/2014, 05:47 PM |
| Q4 2013 |
76 |
$168M |
$0 |
$0 |
|
MNKD, TEVA, ACAD, SRPT, AEGR
|
13F-HR |
2/13/2014, 07:03 PM |